Author Search Results

1

Points from Letters: Value of home visiting by Platten, M C

Published 1977

Get full text
Text

Save to List

Saved in:
2

Emerging targets for anticancer vaccination: IDH by Platten, M., Bunse, L., Wick, W.

Published 2021

Get full text Get full text Get full text
Text

Save to List

Saved in:
3

P04.30 Methadone does not increase toxicity of temozolomide in glioblastoma cells by Latzer, P, Kessler, T, Sahm, F, Rübmann, P, Hielscher, T, Platten, M

Published 2018

Get full text Get full text
Text

Save to List

Saved in:
4

P01.140 An H3.3K27M long peptide vaccine induces expansion of specific CD4 and CD8 T cell clones in a patient with progressive H3.3K27M-mutant midline glioma by Sahm, K, Mildenberger, I, Bunse, L, Green, E, Wick, W, Platten, M

Published 2018

Get full text Get full text
Text

Save to List

Saved in:
5

KS01.6.A Comparative analysis of the immune compartment in human glioblastoma and IDH-mutant WHO grade 4 astrocytoma reveals profound differences in microglia phenotypes by Sankowski, R, Friedrich, M, Bunse, L, Heiland, H H, Platten, M, Prinz, M

Published 2021

Get full text Get full text
Text

Save to List

Saved in:
6

OS06.4A Identification of T cell receptors targeting ZFTA-RELA fusion-positive ependymoma by Kehl, N, Friedrich, M, Kilian, M, Zheng, T, Pajtler, K, Bunse, L, Platten, M

Published 2021

Get full text Get full text
Text

Save to List

Saved in:
7

Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas. by Platten, M., Giordano, M. J., Dirven, C. M., Gutmann, D. H., Louis, D. N.

Published 1996

Get full text Get full text
Text

Save to List

Saved in:
8

OS07.1 Molecular differences in IDH wild type glioblastoma according to MGMT promoter methylation status by Kessler, T., Sahm, F., Sadik, A., Hertenstein, A., Bendszus, M., von Deimling, A., Platten, M., Wick, W.

Published 2017

Get full text Get full text
Text

Save to List

Saved in:
9

P08.19 Resistance towards the MDM2 inhibitor idasanutlin is mediated via the NFkB pathway and IGFBP1 upregulation in glioblastoma by Hertenstein, A., Chiblak, S., Hielscher, T., Ciprut, S., Lemke, D., Thomé, C., Kessler, T., Abdollahi, A., Platten, M., Wick, W.

Published 2017

Get full text Get full text
Text

Save to List

Saved in:
10

OS2.3 A mutation-specific vaccination approach for Histon H3.3 K27M-mutated gliomas by Ochs, K., Ott, M., Bunse, L., Sahm, F., Bunse, T., Deimling, A. von, Wick, W., Platten, M.

Published 2016

Get full text Get full text
Text

Save to List

Saved in:
11

OS09.9 Identification of IDH1R132H-specific T cell receptors from glioma patients and from MHC-humanized mice by Bunse, L., Bunse, T., Sanghvi, K., Green, E., Sahm, F., Omokoko, T., Sahin, U., Schmitt, M., Wick, W., Platten, M.

Published 2017

Get full text Get full text
Text

Save to List

Saved in:
12

OS10.2 R-2-Hydroxyglutarate shapes the immune microenvironment in IDH1-mutant gliomas by Friedrich, M., Bunse, L., Bunse, T., Pusch, S., Sahm, F., Sanghvi, K., Steadman, M., Niemeyer, B., Wick, W., Platten, M.

Published 2017

Get full text Get full text
Text

Save to List

Saved in:
13

OS2.1 Immune responses to a mutation-specific peptide vaccine targeting IDH1R132H in patients with IDH1R132H-mutated gliomas by Bunse, T., Bunse, L., Sahm, F., Omokoko, T., Stevanovic, S., Deimling, A. von, Sahin, U., Schmitt, M., Wick, W., Platten, M.

Published 2016

Get full text Get full text
Text

Save to List

Saved in:
14

OS2.2 Paracrine impairment of antitumor T cell immunity by IDH1-mutant gliomas by Bunse, L., Bunse, T., Pusch, S., Sahm, F., Sanghvi, K., Berghoff, A., Steadman, M., Niemeyer, B., Wick, W., Platten, M.

Published 2016

Get full text Get full text
Text

Save to List

Saved in:
15

OS2.6 Identification of IDH1R132H-specific T cell receptors from a humanized mouse model and from glioma patients treated with an IDH1R132H-specific peptide vaccine by Sanghvi, K., Green, E., Bunse, T., Bunse, L., Sahm, F., Omokoko, T., Sahin, U., Schmitt, M., Wick, W., Platten, M.

Published 2016

Get full text Get full text
Text

Save to List

Saved in:
16

P02.03 Multiple sclerosis and gliomas - a coincidence? by Ochs, K., Capper, D., Sahm, F., Jones, D. T. W., Schrimpf, D., von Deimling, A., Wick, W., Platten, M.

Published 2016

Get full text Get full text
Text

Save to List

Saved in:
17

P04.04 Ex vivo expansion of human glioma-infiltrating lymphocytes alters the exhaustion phenotype of T cells by Deumelandt, K. L., Bunse, T., Bunse, L., Sonner, J. K., Thomé, C., Nadji-Ohl, M., Wick, W., Platten, M.

Published 2016

Get full text Get full text
Text

Save to List

Saved in:
18

O6.09 PROSTAGLANDIN E RECEPTOR-4 ACTIVATION REGULATES TRYPTOPHAN METABOLISM IN HUMAN MALIGNANT GLIOMAS by Ochs, K., Ott, M., Rauschenbach, K.J., Sahm, F., Opitz, C.A., von Deimling, A., Wick, W., Platten, M.

Published 2014

Get full text Get full text
Text

Save to List

Saved in:
19

P01.32 NDRG1 induced downregulation of CCL2 influences the migration of macrophages and impacts the tumor microenvironement by Thomé, C., Blaes, J., Rübmann, P., Hertenstein, A., Kessler, T., Sonner, J., Deumelandt, K., Breckwoldt, M., Platten, M., Wick, W.

Published 2017

Get full text Get full text
Text

Save to List

Saved in:
20

P06.08 BRAINTuNE: Brain Tumor Neoepitope Evaluation for personalized glioma immunotherapy by Sanghvi, K., Green, E., Bunse, L., Balasubramanian, G. P., Hertenstein, A., Bunse, T., Jones, D., Sahm, F., Wick, W., Platten, M.

Published 2017

Get full text Get full text
Text

Save to List

Saved in:

Search Results - Platten, M

Points from Letters: Value of home visiting by Platten, M C

Emerging targets for anticancer vaccination: IDH by Platten, M., Bunse, L., Wick, W.

P04.30 Methadone does not increase toxicity of temozolomide in glioblastoma cells by Latzer, P, Kessler, T, Sahm, F, Rübmann, P, Hielscher, T, Platten, M

P01.140 An H3.3K27M long peptide vaccine induces expansion of specific CD4 and CD8 T cell clones in a patient with progressive H3.3K27M-mutant midline glioma by Sahm, K, Mildenberger, I, Bunse, L, Green, E, Wick, W, Platten, M

KS01.6.A Comparative analysis of the immune compartment in human glioblastoma and IDH-mutant WHO grade 4 astrocytoma reveals profound differences in microglia phenotypes by Sankowski, R, Friedrich, M, Bunse, L, Heiland, H H, Platten, M, Prinz, M

OS06.4A Identification of T cell receptors targeting ZFTA-RELA fusion-positive ependymoma by Kehl, N, Friedrich, M, Kilian, M, Zheng, T, Pajtler, K, Bunse, L, Platten, M

Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas. by Platten, M., Giordano, M. J., Dirven, C. M., Gutmann, D. H., Louis, D. N.

OS07.1 Molecular differences in IDH wild type glioblastoma according to MGMT promoter methylation status by Kessler, T., Sahm, F., Sadik, A., Hertenstein, A., Bendszus, M., von Deimling, A., Platten, M., Wick, W.

P08.19 Resistance towards the MDM2 inhibitor idasanutlin is mediated via the NFkB pathway and IGFBP1 upregulation in glioblastoma by Hertenstein, A., Chiblak, S., Hielscher, T., Ciprut, S., Lemke, D., Thomé, C., Kessler, T., Abdollahi, A., Platten, M., Wick, W.

OS2.3 A mutation-specific vaccination approach for Histon H3.3 K27M-mutated gliomas by Ochs, K., Ott, M., Bunse, L., Sahm, F., Bunse, T., Deimling, A. von, Wick, W., Platten, M.

OS09.9 Identification of IDH1R132H-specific T cell receptors from glioma patients and from MHC-humanized mice by Bunse, L., Bunse, T., Sanghvi, K., Green, E., Sahm, F., Omokoko, T., Sahin, U., Schmitt, M., Wick, W., Platten, M.

OS10.2 R-2-Hydroxyglutarate shapes the immune microenvironment in IDH1-mutant gliomas by Friedrich, M., Bunse, L., Bunse, T., Pusch, S., Sahm, F., Sanghvi, K., Steadman, M., Niemeyer, B., Wick, W., Platten, M.

OS2.1 Immune responses to a mutation-specific peptide vaccine targeting IDH1R132H in patients with IDH1R132H-mutated gliomas by Bunse, T., Bunse, L., Sahm, F., Omokoko, T., Stevanovic, S., Deimling, A. von, Sahin, U., Schmitt, M., Wick, W., Platten, M.

OS2.2 Paracrine impairment of antitumor T cell immunity by IDH1-mutant gliomas by Bunse, L., Bunse, T., Pusch, S., Sahm, F., Sanghvi, K., Berghoff, A., Steadman, M., Niemeyer, B., Wick, W., Platten, M.

OS2.6 Identification of IDH1R132H-specific T cell receptors from a humanized mouse model and from glioma patients treated with an IDH1R132H-specific peptide vaccine by Sanghvi, K., Green, E., Bunse, T., Bunse, L., Sahm, F., Omokoko, T., Sahin, U., Schmitt, M., Wick, W., Platten, M.

P02.03 Multiple sclerosis and gliomas - a coincidence? by Ochs, K., Capper, D., Sahm, F., Jones, D. T. W., Schrimpf, D., von Deimling, A., Wick, W., Platten, M.

P04.04 Ex vivo expansion of human glioma-infiltrating lymphocytes alters the exhaustion phenotype of T cells by Deumelandt, K. L., Bunse, T., Bunse, L., Sonner, J. K., Thomé, C., Nadji-Ohl, M., Wick, W., Platten, M.

O6.09 PROSTAGLANDIN E RECEPTOR-4 ACTIVATION REGULATES TRYPTOPHAN METABOLISM IN HUMAN MALIGNANT GLIOMAS by Ochs, K., Ott, M., Rauschenbach, K.J., Sahm, F., Opitz, C.A., von Deimling, A., Wick, W., Platten, M.

P01.32 NDRG1 induced downregulation of CCL2 influences the migration of macrophages and impacts the tumor microenvironement by Thomé, C., Blaes, J., Rübmann, P., Hertenstein, A., Kessler, T., Sonner, J., Deumelandt, K., Breckwoldt, M., Platten, M., Wick, W.

P06.08 BRAINTuNE: Brain Tumor Neoepitope Evaluation for personalized glioma immunotherapy by Sanghvi, K., Green, E., Bunse, L., Balasubramanian, G. P., Hertenstein, A., Bunse, T., Jones, D., Sahm, F., Wick, W., Platten, M.

Search Tools: